Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin

Article

Abstract: Background. Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor

Palabras claves:

Autores:

Álvarez Blanco J.M., Amador García Y., Avila Albuerne Y., Boris Porras L.G., Carmen Elena Viada, Chao González L., Estrada Guerra Y., Fonseca Chon L., Garabito Perdomo A., González Fernández S., Mojena Martínez L., Pish Martí G., Ramos-Suzarte M., Ricardo Serrano Y.M., Sánchez Valdés L., Santel Odio F.B., Saumell Nápoles Y., Soler Porro L.L., Varona Vázquez L.A.

Fuentes:

scopus